PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation.
about
Recent developments in using mechanistic cardiac modelling for drug safety evaluationPharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.The concept of fraction of drug transported (ft ) with special emphasis on BBB efflux of CNS and antiretroviral drugs.
P2860
PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
PK/PD assessment in CNS drug d ...... to in vivo potency estimation.
@en
PK/PD assessment in CNS drug d ...... to in vivo potency estimation.
@nl
type
label
PK/PD assessment in CNS drug d ...... to in vivo potency estimation.
@en
PK/PD assessment in CNS drug d ...... to in vivo potency estimation.
@nl
prefLabel
PK/PD assessment in CNS drug d ...... to in vivo potency estimation.
@en
PK/PD assessment in CNS drug d ...... to in vivo potency estimation.
@nl
P2093
P1476
PK/PD assessment in CNS drug d ...... to in vivo potency estimation
@en
P2093
Agnès Poirier
Alexander Hillebrecht
Christoph Funk
Franz Schuler
Ruben Alvarez-Sánchez
Sara Belli
Thierry Lavé
P304
P356
10.1016/J.BCP.2013.02.021
P407
P577
2013-02-27T00:00:00Z